Copyright Reports & Markets. All rights reserved.

Global Ophthalmic Anti-inflammatories Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ophthalmic Anti-inflammatories Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Antibacterial
    • 1.3.3 Antiviral
    • 1.3.4 Antifungal
    • 1.3.5 Anti-Parasitic
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ophthalmic Anti-inflammatories Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Ophthalmic Anti-inflammatories Market Size & Forecast
    • 1.5.1 Global Ophthalmic Anti-inflammatories Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Ophthalmic Anti-inflammatories Sales Quantity (2020-2031)
    • 1.5.3 Global Ophthalmic Anti-inflammatories Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Ophthalmic Anti-inflammatories Product and Services
    • 2.1.4 Novartis Ophthalmic Anti-inflammatories Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Valeant Pharmaceuticals
    • 2.2.1 Valeant Pharmaceuticals Details
    • 2.2.2 Valeant Pharmaceuticals Major Business
    • 2.2.3 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Product and Services
    • 2.2.4 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Valeant Pharmaceuticals Recent Developments/Updates
  • 2.3 Allergan
    • 2.3.1 Allergan Details
    • 2.3.2 Allergan Major Business
    • 2.3.3 Allergan Ophthalmic Anti-inflammatories Product and Services
    • 2.3.4 Allergan Ophthalmic Anti-inflammatories Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Allergan Recent Developments/Updates
  • 2.4 Santen Pharmaceutical
    • 2.4.1 Santen Pharmaceutical Details
    • 2.4.2 Santen Pharmaceutical Major Business
    • 2.4.3 Santen Pharmaceutical Ophthalmic Anti-inflammatories Product and Services
    • 2.4.4 Santen Pharmaceutical Ophthalmic Anti-inflammatories Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Santen Pharmaceutical Recent Developments/Updates
  • 2.5 Lupin Pharmaceuticals
    • 2.5.1 Lupin Pharmaceuticals Details
    • 2.5.2 Lupin Pharmaceuticals Major Business
    • 2.5.3 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Product and Services
    • 2.5.4 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Lupin Pharmaceuticals Recent Developments/Updates
  • 2.6 Apotex
    • 2.6.1 Apotex Details
    • 2.6.2 Apotex Major Business
    • 2.6.3 Apotex Ophthalmic Anti-inflammatories Product and Services
    • 2.6.4 Apotex Ophthalmic Anti-inflammatories Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Apotex Recent Developments/Updates
  • 2.7 Akorn
    • 2.7.1 Akorn Details
    • 2.7.2 Akorn Major Business
    • 2.7.3 Akorn Ophthalmic Anti-inflammatories Product and Services
    • 2.7.4 Akorn Ophthalmic Anti-inflammatories Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Akorn Recent Developments/Updates

3 Competitive Environment: Ophthalmic Anti-inflammatories by Manufacturer

  • 3.1 Global Ophthalmic Anti-inflammatories Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Ophthalmic Anti-inflammatories Revenue by Manufacturer (2020-2025)
  • 3.3 Global Ophthalmic Anti-inflammatories Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Ophthalmic Anti-inflammatories by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Ophthalmic Anti-inflammatories Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Ophthalmic Anti-inflammatories Manufacturer Market Share in 2024
  • 3.5 Ophthalmic Anti-inflammatories Market: Overall Company Footprint Analysis
    • 3.5.1 Ophthalmic Anti-inflammatories Market: Region Footprint
    • 3.5.2 Ophthalmic Anti-inflammatories Market: Company Product Type Footprint
    • 3.5.3 Ophthalmic Anti-inflammatories Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ophthalmic Anti-inflammatories Market Size by Region
    • 4.1.1 Global Ophthalmic Anti-inflammatories Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Ophthalmic Anti-inflammatories Consumption Value by Region (2020-2031)
    • 4.1.3 Global Ophthalmic Anti-inflammatories Average Price by Region (2020-2031)
  • 4.2 North America Ophthalmic Anti-inflammatories Consumption Value (2020-2031)
  • 4.3 Europe Ophthalmic Anti-inflammatories Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Ophthalmic Anti-inflammatories Consumption Value (2020-2031)
  • 4.5 South America Ophthalmic Anti-inflammatories Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Ophthalmic Anti-inflammatories Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Ophthalmic Anti-inflammatories Sales Quantity by Type (2020-2031)
  • 5.2 Global Ophthalmic Anti-inflammatories Consumption Value by Type (2020-2031)
  • 5.3 Global Ophthalmic Anti-inflammatories Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Ophthalmic Anti-inflammatories Sales Quantity by Application (2020-2031)
  • 6.2 Global Ophthalmic Anti-inflammatories Consumption Value by Application (2020-2031)
  • 6.3 Global Ophthalmic Anti-inflammatories Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Ophthalmic Anti-inflammatories Sales Quantity by Type (2020-2031)
  • 7.2 North America Ophthalmic Anti-inflammatories Sales Quantity by Application (2020-2031)
  • 7.3 North America Ophthalmic Anti-inflammatories Market Size by Country
    • 7.3.1 North America Ophthalmic Anti-inflammatories Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Ophthalmic Anti-inflammatories Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Ophthalmic Anti-inflammatories Sales Quantity by Type (2020-2031)
  • 8.2 Europe Ophthalmic Anti-inflammatories Sales Quantity by Application (2020-2031)
  • 8.3 Europe Ophthalmic Anti-inflammatories Market Size by Country
    • 8.3.1 Europe Ophthalmic Anti-inflammatories Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Ophthalmic Anti-inflammatories Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ophthalmic Anti-inflammatories Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Ophthalmic Anti-inflammatories Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Ophthalmic Anti-inflammatories Market Size by Region
    • 9.3.1 Asia-Pacific Ophthalmic Anti-inflammatories Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Ophthalmic Anti-inflammatories Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Ophthalmic Anti-inflammatories Sales Quantity by Type (2020-2031)
  • 10.2 South America Ophthalmic Anti-inflammatories Sales Quantity by Application (2020-2031)
  • 10.3 South America Ophthalmic Anti-inflammatories Market Size by Country
    • 10.3.1 South America Ophthalmic Anti-inflammatories Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Ophthalmic Anti-inflammatories Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ophthalmic Anti-inflammatories Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Ophthalmic Anti-inflammatories Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Ophthalmic Anti-inflammatories Market Size by Country
    • 11.3.1 Middle East & Africa Ophthalmic Anti-inflammatories Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Ophthalmic Anti-inflammatories Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Ophthalmic Anti-inflammatories Market Drivers
  • 12.2 Ophthalmic Anti-inflammatories Market Restraints
  • 12.3 Ophthalmic Anti-inflammatories Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ophthalmic Anti-inflammatories and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ophthalmic Anti-inflammatories
  • 13.3 Ophthalmic Anti-inflammatories Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ophthalmic Anti-inflammatories Typical Distributors
  • 14.3 Ophthalmic Anti-inflammatories Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ophthalmic Anti-inflammatories market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    Ophthalmic anti-inflammatories are a group of medications that are used to treat inflammatory eye conditions, such as allergic conjunctivitis, non-infectious uveitis, and to treat eye inflammation after an ophthalmic procedure.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Ophthalmic Anti-inflammatories market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ophthalmic Anti-inflammatories market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Ophthalmic Anti-inflammatories market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Ophthalmic Anti-inflammatories market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Ophthalmic Anti-inflammatories market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ophthalmic Anti-inflammatories
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ophthalmic Anti-inflammatories market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Valeant Pharmaceuticals, Allergan, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ophthalmic Anti-inflammatories market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Antibacterial
    Antiviral
    Antifungal
    Anti-Parasitic
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Novartis
    Valeant Pharmaceuticals
    Allergan
    Santen Pharmaceutical
    Lupin Pharmaceuticals
    Apotex
    Akorn
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ophthalmic Anti-inflammatories product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ophthalmic Anti-inflammatories, with price, sales quantity, revenue, and global market share of Ophthalmic Anti-inflammatories from 2020 to 2025.
    Chapter 3, the Ophthalmic Anti-inflammatories competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ophthalmic Anti-inflammatories breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ophthalmic Anti-inflammatories market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Anti-inflammatories.
    Chapter 14 and 15, to describe Ophthalmic Anti-inflammatories sales channel, distributors, customers, research findings and conclusion.

    Buy now